Buccal Bioadhesive Delivery System of 5-Fluorouracil: Optimization and Characterization

REFERENCES

• Agrawal V., Mishra B. Design, development and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev. Ind. Pharm. 1999; 25: 701–709
   PubMed Web of Science ®Google Scholar
• Ahuja A., Khar R. K., Ali J. Mucoadhesive drug delivery. Drug Dev.Ind. Pharm. 1997; 23: 489–515
   Web of Science ®Google Scholar
• Alur H. H., Beal J. D., Pather S. I., Mitra A. K., Johnston T. P. Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets. J. Pharm. Sci. 1999; 88: 1313–1319
   PubMed Web of Science ®Google Scholar
• Attia M. A., El Gibaly I., Shaltout S. E., Fetih G. N. Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels. Int. J. Pharm. 2004; 276: 11–28
   PubMed Web of Science ®Google Scholar
• Benes L., Claustrat B., Horriere F., Geoffriau M., Konsil J., Parrott K. A., DeGrande G., McQuinn R. L., Ayres J. W. Transmucosal, oral controlled release, and transdermal drug administration in human subjects: A crossover study with melatonin. J. Pharm. Sci. 1997; 86: 1115–1119
   PubMed Web of Science ®Google Scholar
• Bouckaert S., Massart D. L., Massart B., Rremon J. P. Optimization of a granulation procedure for a hydrophilic matrix tablet design. Drug Dev. Ind. Pharm. 1996; 22: 321–327
   Web of Science ®Google Scholar
• Chidambaram N., Srivastava A. K. Buccal drug delivery systems. Drug Dev. Ind. Pharm. 1995; 21: 1009–1036
   Web of Science ®Google Scholar
• Clas D. S., Dalton C. R., Hancock B. C. Differential scanning calorimetry: Applications in drug development. Pharm. Sci. Technol. Today 1999; 2(8)311–319
   PubMedGoogle Scholar
• Desai K. G. H., Kumar T. M. P. Preparation and evaluation of a novel buccal adhesive system. AAPS Pharm. Sci. Technol. 2004; 5, article 35.
   PubMed Web of Science ®Google Scholar
• Diasio R. B., Harris B. E. Clinical pharmacology of 5-fluorouracil. Clin. Pharmacokinet. 1989; 16: 215–237
   PubMed Web of Science ®Google Scholar
• Therapeutic drugs 2nd, C. Dollery. Churchill Livingstone, Edinburgh 1999; 1: F103–F108
   Google Scholar
• Ford J. L., Rubinstein M. H., Hogan J. E. Formation of sustained release promethazine hydrochloride tablets using hydroxypropylmethylcellulose matrix. Int. J. Pharm. 1985; 24: 327–338
   Web of Science ®Google Scholar
• Gantrez Brochure. International Speciality Products Ltd, Wayne, NJ 2005
   Google Scholar
• Hoogstraate A. J., Verhoef J. C., Tuk B., Pijpers A., Van Leengoed L. A. M. G, Verheijden J. H. M., Junginger H. E., Bodde H. Buccal delivery of fluorescein isothiocyanate–dextran 4400 and the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs. J. Control. Release 1996; 41(1–2)77–84
   Web of Science ®Google Scholar
• Hoogstraate A. J., Wertz P. W. Drug delivery via the buccal mucosa. Pharm. Sci. Technol. Today 1998; 1: 309–316
   Google Scholar
• Huang Y. B., Tsai Y. H., Lee S. H., Chang J. S., Wu P. C. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int. J. Pharm. 2005; 289(1–2)87–95
   PubMed Web of Science ®Google Scholar
• Huang Y. B., Tsai Y. H., Yang W. C., Chang J. S., Wu P. C. Optimization of sustained-release propranolol dosage form using factorial design and response surface methodology. Biol. Pharm. Bull. 2004; 27: 1626–1629
   PubMed Web of Science ®Google Scholar
• Huang Y. B., Tsai Y. H., Yang W. C., Chang J. S., Wu P. C., Takayama K. Once-daily propranolol extended-release tablet dosage form: Formulation design and in vitro/in vivo investigation. Eur. J. Pharm. Biopharm. 2004; 58: 607–614
   PubMed Web of Science ®Google Scholar
• Jay S., Fountain W., Cui Z., Mumper R. J. Transmucosal delivery of testosterone in rabbits using novel bi-layer mucoadhesive wax-film composite disks. J. Pharm. Sci. 2002; 91: 2016
   PubMed Web of Science ®Google Scholar
• Jonnalagadda S., Robinson D. H. A bioresorbable, polylactide reservoir for diffusional and osmotically controlled drug delivery. AAPS Pharm. Sci. Technol. 2000; 1(4), article 29.
   PubMedGoogle Scholar
• Korsmeyer R. W., Gurny R., Doelker E., Buri P., Peppas N. A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983; 15: 25–35
   Web of Science ®Google Scholar
• Lahdenpaa E., Niskanen M., Yliruusi J. Crushing strength, disintegration time and weight variation of tablets compressed from three avicel pH grades and their mixtures. Eur. J. Pharm. Biopharm. 1997; 42: 315–322
   Web of Science ®Google Scholar
• Li C., Bhatt P. P., Johnston T. P. Transmucosal delivery of oxytocin to rabbits using a mucoadhesive buccal patch. Pharm. Dev. Technol. 1997; 2: 265–274
   PubMedGoogle Scholar
• Mehta A. K., Yadav K. S., Sawant K. K. Nimodipine loaded PLGA nanoparticles: Formulation optimization using factorial design, characterization and in vitro evaluation. Curr. Drug Del. 2007; 4: 185–193
   PubMedGoogle Scholar
• Miyazaki S., Kawasaki N., Nakamura T., Iwatsu M., Hayashi T., Hou M., Attwood D. Oral mucosal bioadhesive tablets of pectin and HPMC: In vitro and in vivo evaluation. Int. J. Pharm. 2000; 204: 127–132
   PubMed Web of Science ®Google Scholar
• Nafee N. A., Ismail F. A., Boraie N. A., Mortada L. M. Mucoadhesive buccal patches of miconazole nitrate: In vitro/in vivo performance and effect of ageing. Int. J. Pharm. 2003; 264: 1–14
   PubMed Web of Science ®Google Scholar
• Narendra C., Srinath M. S., Prakash Rao B. Development of three layered buccal compact containing metoprolol tartrate by statistical optimization technique. Int. J. Pharm. 2005; 304: 102–114
   PubMed Web of Science ®Google Scholar
• Owens T. S., Dansereau R. J., Sakr A. Development and evaluation of extended release bioadhesive sodium fluoride tablets. Int. J. Pharm. 2005; 288: 109–122
   PubMed Web of Science ®Google Scholar
• Patel V. M., Prajapati B. G., Patel M. M. Effect of hydrophilic polymers on buccoadhesive eudragit patches of propranolol hydrochloride using factorial design. AAPS Pharm. Sci. Technol. 2007; 8(2), article 45.
   Web of Science ®Google Scholar
• Peppas N. A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta. Helv. 1985; 60: 110–111
   PubMedGoogle Scholar
• Prakobvaitayakit M., Nimmannit U. Optimization of polylactic-co-glycolic acid nanoparticles containing itraconazole using 23 factorial design. AAPS Pharm. Sci. Technol. 2003; 4(4), article 71.
   PubMedGoogle Scholar
• Sako K., Sawada T., Nakashima H., Yokohama S., Sonobe T. Influence of water soluble fillers on hydroxypropylmethylcellulose matrix on in vitro and in vivo drug release. J. Control. Release 2002; 81: 165–172
   PubMed Web of Science ®Google Scholar
• Schechter N. L., Weisman S. J., Rosenblum M., Bernstein B., Conard P. L. The use of oral transmucosal fentanyl citrate for painful procedures in children. Pediatrics 1995; 95: 335–339
   PubMed Web of Science ®Google Scholar
• Schwagmeier R., Alincic S., Striebel H. W. Midazolam pharmacokinetics following intravenous and buccal administration. Br. J. Clin. Pharmacol. 1998; 46: 203–206
   PubMed Web of Science ®Google Scholar
• Shin S. C., Bum J. P., Choi J. S. Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits. Int. J. Pharm. 2000; 209: 37–43
   PubMed Web of Science ®Google Scholar
• Shin S. C., Cho C. W., Yang K. H. Development of lidocaine gels for enhanced local anesthetic action. Int. J. Pharm. 2004; 287: 73–78
   PubMed Web of Science ®Google Scholar
• Singh B., Ahuja N. Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: Optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev. Ind. Pharm. 2002; 28: 431–442
   PubMed Web of Science ®Google Scholar
• Singh B., Chakkal S. K., Ahuja N. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS Pharm. Sci. Tech. 2006; 7(1), article 3.
   Web of Science ®Google Scholar
• Singh S. K., Dodge J., Durrani M. J., Khan M. Factorial design in the feasibility of producing microcel MC-101 pellets by extrusion spheronization. Int. J. Pharm. 1995; 115: 53–60
   Web of Science ®Google Scholar
• Smart J. D. Drug delivery using buccal-adhesive systems. Adv. Drug Del. Rev. 1993; 11: 1253–270
   Web of Science ®Google Scholar
• Tsutsumi K., Obata Y., Nagai T., Loftsson T., Takayama K. Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea-pigs. Int. J. Pharm. 2002; 238: 161–170
   PubMed Web of Science ®Google Scholar
• Vandervoort J., Ludwig A. Preparation factors affecting the properties of polylactide nanoparticles: A factorial design study. Pharmazie 2001; 56: 484–488
   PubMed Web of Science ®Google Scholar
• Varma M., Singla A. K., Dhawan S. Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol. Drug Dev. Ind. Pharm. 2004; 30: 545–553
   PubMed Web of Science ®Google Scholar
• Voorspoels J., Remon J. P., Eechaute W., De Sy W. Buccal absorption of testosterone and its esters using a bioadhesive tablet in dogs. Pharm. Res. 1996; 13: 1228–1232
   PubMed Web of Science ®Google Scholar
• Zuleger S., Lippold B. C. Polymer particle erosion controlling drug release: I. Factors influencing drug release and characterization of the release mechanism. Int. J. Pharm. 2001; 217: 139–152
   PubMed Web of Science ®Google Scholar